Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3514)
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
40,401
Price
$5.87
Total Value
$236.95K
Shares Held After
1,862,567
% of Holdings
2.1%
ARDELYX, INC. (ARDX)
Brady James Parker — Chief Human Resources Officer
Shares
309
Price
$5.71
Total Value
$1.77K
Shares Held After
262,912
% of Holdings
0.1%
ARDELYX, INC. (ARDX)
Brady James Parker — Chief Human Resources Officer
Shares
2,234
Price
$5.87
Total Value
$13.10K
Shares Held After
263,221
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Kelliher Mike — See Remarks
Shares
2
Price
$5.71
Total Value
$11.41
Shares Held After
364,666
% of Holdings
0.0%
ARDELYX, INC. (ARDX)
Williams Laura A — See Remarks
Shares
984
Price
$5.71
Total Value
$5.62K
Shares Held After
436,082
% of Holdings
0.2%
ARDELYX, INC. (ARDX)
Kelliher Mike — See Remarks
Shares
1,159
Price
$5.71
Total Value
$6.62K
Shares Held After
364,668
% of Holdings
0.3%
ARDELYX, INC. (ARDX)
Williams Laura A — See Remarks
Shares
7,192
Price
$5.87
Total Value
$42.18K
Shares Held After
437,066
% of Holdings
1.6%
ARDELYX, INC. (ARDX)
Kelliher Mike — See Remarks
Shares
8,434
Price
$5.87
Total Value
$49.47K
Shares Held After
365,827
% of Holdings
2.3%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
1
Price
$5.70
Total Value
$5.70
Shares Held After
425,970
% of Holdings
0.0%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
1
Price
$5.71
Total Value
$5.71
Shares Held After
425,971
% of Holdings
0.0%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
1,261
Price
$5.71
Total Value
$7.21K
Shares Held After
425,972
% of Holdings
0.3%
ARDELYX, INC. (ARDX)
Foster Eric Duane — Chief Commercial Officer
Shares
9,176
Price
$5.87
Total Value
$53.82K
Shares Held After
427,233
% of Holdings
2.1%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
100,000
Price
$1.48
Total Value
$147.79K
Shares Held After
1,804,186
% of Holdings
5.5%
MapLight Therapeutics, Inc. (MPLT)
Pavlov George — Director
Shares
9,920
Price
$17.86
Total Value
$177.17K
Shares Held After
25,000
% of Holdings
39.7%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
600
Price
$88.10
Total Value
$52.86K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Esposito Pamela — Director
Shares
1,900
Price
$87.06
Total Value
$165.41K
Shares Held After
600
% of Holdings
76.0%
Roivant Sciences Ltd. (ROIV)
Torti Frank — President and Vant Chair
Shares
1,400,000
Price
$27.42
Total Value
$38.39M
Shares Held After
13,736,547
% of Holdings
9.2%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
10,834
Price
$262.10
Total Value
$2.84M
Shares Held After
78,691
% of Holdings
12.1%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
8,116
Price
$260.49
Total Value
$2.11M
Shares Held After
89,525
% of Holdings
8.3%
EXELIXIS, INC. (EXEL)
Aftab Dana — EVP, Research and Development
Shares
29,873
Price
$44.35
Total Value
$1.32M
Shares Held After
664,024
% of Holdings
4.3%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
590
Price
$69.82
Total Value
$41.19K
Shares Held After
105,212
% of Holdings
0.6%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
212
Price
$68.54
Total Value
$14.53K
Shares Held After
105,802
% of Holdings
0.2%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,629
Price
$69.82
Total Value
$113.74K
Shares Held After
106,014
% of Holdings
1.5%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
588
Price
$68.54
Total Value
$40.30K
Shares Held After
107,643
% of Holdings
0.5%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,030
Price
$153.38
Total Value
$157.98K
Shares Held After
301,185
% of Holdings
0.3%
INSMED Inc (INSM)
Lewis William — Director
Shares
2,377
Price
$151.92
Total Value
$361.11K
Shares Held After
302,215
% of Holdings
0.8%
INSMED Inc (INSM)
Lewis William — Director
Shares
3,413
Price
$151.12
Total Value
$515.77K
Shares Held After
304,592
% of Holdings
1.1%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,891
Price
$150.10
Total Value
$283.84K
Shares Held After
308,005
% of Holdings
0.6%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,988
Price
$149.17
Total Value
$296.55K
Shares Held After
309,896
% of Holdings
0.6%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
602
Price
$72.80
Total Value
$43.83K
Shares Held After
234,451
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
8,528
Price
$72.08
Total Value
$614.70K
Shares Held After
235,053
% of Holdings
3.5%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
18,923
Price
$71.03
Total Value
$1.34M
Shares Held After
243,581
% of Holdings
7.2%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
4
Price
$790.00
Total Value
$3.16K
Shares Held After
1,703
% of Holdings
0.2%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
56
Price
$785.61
Total Value
$43.99K
Shares Held After
1,707
% of Holdings
3.2%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
160
Price
$784.45
Total Value
$125.51K
Shares Held After
1,763
% of Holdings
8.3%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
220
Price
$783.29
Total Value
$172.32K
Shares Held After
1,923
% of Holdings
10.3%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
298
Price
$782.10
Total Value
$233.07K
Shares Held After
2,143
% of Holdings
12.2%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
209
Price
$781.28
Total Value
$163.29K
Shares Held After
2,441
% of Holdings
7.9%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
331
Price
$780.45
Total Value
$258.33K
Shares Held After
2,650
% of Holdings
11.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
208
Price
$779.55
Total Value
$162.15K
Shares Held After
2,981
% of Holdings
6.5%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
53
Price
$778.47
Total Value
$41.26K
Shares Held After
3,189
% of Holdings
1.6%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
50
Price
$775.50
Total Value
$38.77K
Shares Held After
3,242
% of Holdings
1.5%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
49
Price
$774.68
Total Value
$37.96K
Shares Held After
3,292
% of Holdings
1.5%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, R&D
Shares
18,668
Price
$100.91
Total Value
$1.88M
Shares Held After
234,800
% of Holdings
7.4%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Sachdev Amit — EVP Chief Patient & Ext Af Off
Shares
4,237
Price
$471.43
Total Value
$2.00M
Shares Held After
58,934
% of Holdings
6.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Sachdev Amit — EVP Chief Patient & Ext Af Off
Shares
11,712
Price
$470.54
Total Value
$5.51M
Shares Held After
63,171
% of Holdings
15.6%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Sachdev Amit — EVP Chief Patient & Ext Af Off
Shares
7,241
Price
$469.61
Total Value
$3.40M
Shares Held After
74,883
% of Holdings
8.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Sachdev Amit — EVP Chief Patient & Ext Af Off
Shares
19,662
Price
$468.57
Total Value
$9.21M
Shares Held After
82,124
% of Holdings
19.3%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Sachdev Amit — EVP Chief Patient & Ext Af Off
Shares
10,263
Price
$467.75
Total Value
$4.80M
Shares Held After
101,786
% of Holdings
9.2%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Sachdev Amit — EVP Chief Patient & Ext Af Off
Shares
1,848
Price
$465.80
Total Value
$860.80K
Shares Held After
112,049
% of Holdings
1.6%
Showing 1901–1950 of 3514 transactions (page 39 of 71)